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Summary 
A new, numerically minute population of cells representing the earliest T precursor cells in the 
adult mouse thymus has recently been isolated.  This population has been shown to be similar 
to bone marrow hemopoietic stem cells in surface antigenic phenotype and to express moderate 
levels of CD4. We now show, by fluorescence-activated  cell sorting and intrathymic transfer 
to irradiated mice, that this apparently homogeneous population differs from muhipotent stem 
cells in expressing the surface stem cell antigen 2 (Sca-2), that it differs from most early B lineage 
cells in lacking B220 and class II major histocompatibility complex expression, and that it binds 
rhodamine 123 like an activated rather than a quiescent cell. Irradiated recipient mice differing 
at the Ly 5 locus were used to compare the developmental potential of these early intrathymic 
precursors with bone marrow stem cells. Only T lineage product cells were detected when the 
intrathymic precursor population was transferred back into an irradiated thymus. However, when 
the intrathymic precursor population was transferred intravenously,  it displayed the capacity to 
develop into both B and T lymphoid cells in recipient bone marrow, spleen, and lymph nodes, 
but no donor-derived myeloid cells were detected. The absence of myeloid and erythroid precursor 
activity was confirmed by showing that the intrathymic precursor population was unable to 
develop into myeloid or erythroid spleen colonies on intravenous transfer  or to form colonies 
in an agar culture. These findings indicate that this earliest intrathymic precursor population 
has become restricted (or strongly biased) to lymphoid lineage development, but not exclusively 
to T  lymphocytes. 
T 
he ultimate origin of T lymphocytes is the same as that 
of other hemopoietic cells, namely a muhipotent stem 
cell found in fetal liver and adult bone marrow (1-3). A con- 
tinuous but low input from bone marrow of some form of 
stem cell or "prothymocyte" appears necessary to maintain 
T  cell development in the adult thymus (4). A prothymo- 
cyte-like population, of which virtually every cell was able 
to colonize an irradiated thymus on intrathymic transfer, has 
been purified from adult mouse bone marrow (5, 6). Since 
each cell of this kind was also able to reconstitute erythroid, 
myeloid, and B lymphoid lineages, this precursor was a form 
of muhipotent hemopoietic stem cell.  This purified bone 
marrow stem cell expressed low levels of Thy-1 but had no 
detectable expression of other hemopoietic lineage markers; 
it was positive for stem cell antigen-1 (Sca-1;  1 Ly 6A/E), 
Pgp-1 (CD44), heat stable antigen (HSA),  and MHC class 
1 Abbreviations  used in  this paper: HSA,  heat-stable antigen; Lin- BM, 
lineage marker-negative bone marrow; Rh-123, rhodamine 123; Sca, stem 
cell antigen. 
I. However, it is not clear whether this is the cell that nor- 
mally migrates through the blood to colonize the thymus. 
In attempting to clarify this issue, it is important to identify 
the earliest intrathymic precursors that might represent a point 
of connection with the cells seeding the thymus from bone 
marrow and to test their developmental capacity. 
The earliest intrathymic precursor population so far observed 
in the adult thymus has been isolated recently in this labora- 
tory as a minute population that expressed moderate levels 
of mature T cell marker CD4 (7). This population, termed 
the "low CD4 precursor," resembled the bone marrow hemo- 
poietic stem cell in surface antigenic phenotype (Thy-1 +, 
HSA +  , Pgp-12+ , H-2K  2+ , and Sca-1  +) and had TCR and 
Ig genes in germline state. On intrathymic transfer to irradi- 
ated animals this low CD4 precursor population showed slower 
reconstitution kinetics and higher expansion potential than 
the CD4-8-  thymocytes, previously considered the earliest 
precursors  (8).  The  T  cells  produced included both  the 
TCR-edB and "7/6 T  lineages (7, 9). These findings sug- 
gest that cells within the low CD4 precursor population were 
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stem cell. 
Since this intrathymic low CD4  precursor  shared many 
properties with bone marrow stem cells, it was important 
to ask whether it was also multipotent. To answer this ques- 
tion, we transferred the low CD4 precursors intravenously 
to irradiated recipients and so compared their developmental 
potential with that of bone marrow stem cells.  Our studies 
demonstrate that the earliest intrathymic precursor cells differ 
from bone marrow stem cells, having lost the capacity to de- 
velop into erythroid and myeloid cells and having become 
restricted or strongly biased to lymphoid lineage development. 
Materials  and Methods 
Mice.  Mice of C57BL/Ka Thy-l.2, C57BL/Ka Thy-l.1, and 
C57BL/6-Ly 5.1-Pep  3b strains were bred at The Walter and Eliza 
Hall Institute Animal Facility. For intrathymic T lineage repopu- 
lation experiments, C57BL/Ka Thy-l.2 (Ly 5.2) and the Thy-l-con- 
genic C57BL/Ka Thy-l.1 (Ly 5.2) mice were used interchangeably 
as donors and recipients (4-6 wk of age as donors or 8-12 wk of 
age  as  recipients).  For  hematopoietic  lineage  reconstitution, 
C57BL/Ka Tby-l.1 (Ly 5.2) mice 4-6 wk of  age were used as donors, 
and C57BL/6-Ly 5.1-Pep  3b (Thy-l.2, Ly 5.1) mice at 8-12 wk of 
age were used as recipients. 
Monoclonal Antibodies and Fluorescent Reagents.  The antibodies 
used for cytotoxic depletion were: anti-CD8, clone H0-2.2 (10); 
anti-CD3, clone 17A2 (11); and anti-II.-2R~x, clone 7D4 (12). The 
antibodies used for magnetic bead depletion were: anti-CD8, clone 
53-6.7 (13); anti-CD3, done KT3-1.1 (14); anti-IL-2R, clone PC61 
(15); anti-CD2, clone RM2-1 (16); anti-B220, clone RA3-6B2 (17); 
anti-Mac-I, clone M1/70.15  (18); anti-Gr-1, clone RB6-8C5 (19); 
and antierythrocyte antigen, clone TER-119 (derived by Tatsuo Kina 
and colleagues, Department of Immunology, Chest Disease Re- 
search Institute, Kyoto University,  Kyoto, Japan).  All the above 
were used as either culture supematants or ascitic fluid. The purified 
antibodies used for immunofluorescent staining were: anti-Tby-l.1, 
clone 19F-12 (20), used as a direct FITC conjugate; anti-HSA, clone 
M1/69 (18) used as a PE conjugate or allophycocyanin (APC) con- 
jugate; anti-H-2K  b, clone B8-24-3 (21), used as a biotinylated con- 
jugate; anti-Ly 5.2, clone AL1-4A2 (6), used as a FITC conjugate; 
anti-B220, anti-Mac-I, and anti-Gr-1 (clones described above), were 
used as biotinylated conjugates.  The fluorescent reagents used for 
second stage staining were PE-avidin (PE-Av), coumarin-avidin (Co- 
Av), Texas  red-avidin (TR-Av), and PE-anti-rat Ig (all from Caltag 
Laboratories, San Francisco, CA). 
Iramunofluorescent Staining and Cell Sortin,r  Two- and three-color 
fluorescent staining procedures were similar to those described pre- 
viously (7, 22). Flow cytometric analysis or sorting was performed 
on FACStar Plus  |  (Becton Dickinson & Co., Mountain View, CA). 
Dead cells were gated out on the basis of forward light scatter and 
propidium iodide (PI) staining.  For analysis, 25,000-50,000  cells 
were collected in each file. When sorting was performed, the pu- 
rity of the sorted population was determined by reanalysis. 
Isolation of  Low CD4 Intrathymic Precursor Cells.  The procedure 
was basically as described previously (7). Thymocyte suspensions 
from 16-24 thymuses of 4-6-wk-old C57BL/Ka mice were sub- 
jected to two successive depletion procedures to remove CD4 +  8 + 
cortical thymocytes, CD3 + mature medullary thymocytes, most 
of the  CD4-8-  precursor  cells, and  non-T  lineage  cells, all 
without depletion on the basis of CD4 expression. The first step 
was complement-mediated cytotoxicity using antibodies  against 
CD8, CD3, and Ib2Rc~. Dead cells were then removed by metriza- 
mide density cut. In some experiments,  where noted, adherent 
macrophage-like cells were depleted at this stage by incubating cells 
(suspended in RPMI 1640 containing 10% FCS) in a plastic petri 
dish at 37~  for 90 rain. The nonadherent cells were collected by 
gently washing the dish three times with warm medium. Residual 
contaminants and further unwanted cells were removed by coating 
the cells with anti-CD8, anti-CD3, anti-IL-2R~, anti-CD2, and 
with antibodies against erythrocytes (TER-119), granulocytes (anti- 
Gr-1), macrophages (anti-Mac-I),  and B cells (anti-B220 and anti- 
Ig), then removing the coated cells with anti-Ig--coated magnetic 
beads (using an 8:1 ratio of beads to cells and a mixture of three 
parts anti-rat Ig and one part anti-mouse Ig Dynabeads [Dynal 
Inc., Oslo, Norway]). In some experiments,  where noted, deple- 
tion of B220-bearing cells was omitted. The fully depleted popula- 
tion, now representing <1% of thymocytes, was stained in three 
fluorescent  colors with PE-anti-HSA, FITC-anti-Thy-1,  and bi- 
otin-anti-H-2K  b, followed by staining with Texas red-avidin.  The 
stained cells were then sorted for cells expressing low but positive 
levels of Thy-1, moderate levels of HSA,  and very high levels of 
H-2K.  All these  Thy-1 +,  HSA §  and H-2K  z+  cells have been 
shown previously to express moderate levels of CD4 (7), althoug  h 
this was not used as a sorting parameter in the present study. Reanal- 
),sis showed that the purity of the sorted population was >97%. 
Preparation of  Low Thy-1, Low HSA, and Lineage Marker-negative 
Bone Marrow Cells (Lin- BM).  This preparation  represented  an 
enriched source ofbemopoietic stem cells, depleted of most lineage- 
committed precursors. Bone marrow cells were obtained from adult 
C57BL/Ka Tby-l.1 mice. Erythrocytes and dead cells were removed 
as previously described (23). Lineage marker-positive bone marrow 
cells were then depleted with antibodies against macrophages (anti- 
Mac-l), granulocytes (anti-Gr-1),  erythrocytes (TER-119),  and B 
lymphocytes (anti-B220),  followed  by anti-Ig--coated  magnetic 
beads. The depleted cells were stained in three colors in the fol- 
lowing sequence: (a) cells were coated with the same antibodies 
used for magnetic bead depletion, followed by PE-conjugated goat 
anti-rat Ig as second stage; (b) this second stage was then blocked 
with rat Ig; (c) the cells were then stained simultaneously with 
FITC-anti-Thy-l.1 and APC-anti-HSA. The Lin- BM cells were 
obtained by sorting for cells that were negative for lineage markers 
and low positive  for both Thy-1 and HSA. 
Thymic Reconstitution Assay.  The procedure has been described 
in detail (24). The Thy-1 congenic recipient mice were irradiated 
(7.5 Gy 3' irradiation)  and used 1-3 h later. The cells in 10/~1 of 
balanced salt solution were injected directly into a single lobe of 
the recipient thymus. At various times after transfer, cell suspen- 
sions were prepared from the injected recipient thymus lobes and 
stained with FITC-conjugated antibodies  against the donor-type 
Thy-1  (in  some  experiments  Ly 5),  together  with  anti-CD4 
(PE-conjugated) and anti-CD8 (biotinylated,  with Co-Av second 
stage). The stained ceils were then analyzed by flow cytometry, 
gating for Thy-1 + donor-derived  cells. 
Spleen Colony Forming Assay.  The procedure was similar to that 
of Till et al. (25) and Molineux et al. (26). The recipient mice were 
given two doses of 5.5 Gy 3, irradiation with a 3-h interval be- 
tween, then used ,~1 h later. Various numbers of the test precursor 
cells were injected intravenously. To help maintain the mice, neo- 
mycin sulfate (1.1 g/liter) was included in the drinking water. The 
spleens were removed 8 or 12 d after transfer and fixed in Bouin's 
solution for direct macroscopic surface counts of spleen colonies 
or for sectioning for histological  examination. 
Lineage Reconstitution Assay Using the Ly 5 Marker.  The proce- 
dure was similar to that of Spangmde et al. (6). The Ly 5.1 recip- 
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tion with a 3-h interval between) and then used "~1 h later. The 
donor cells from Ly 5.2 mice were injected intravenously,  along 
with 4  x  104 Ly 5.1 (recipient type) unfractionated bone marrow 
cells, to ensure long-term survival of the recipients. Antibiotics (poly- 
myxin B sulfate, 104 U/liter; neomycin sulfate, 1.1 g/liter) were 
added to the drinking water. 2-8 wk after transfer, the spleen and 
lymph nodes (pooled),  the thymus, and the bone marrow were 
collected from recipients.  Cells were stained in two colors with 
donor-specific  anti-Ly 5.2  (FITC--conjugated)  and biotinylated 
lineage-specific  antibodies  (either anti-Thy-l.1,  anti-B220,  anti- 
Mac-l, or anti-Gr-1),  followed by PE--avidin for the second stage. 
In some experiments,  where noted, tliree-color staining was used 
for analysis. In such experiments cell suspensions were stained with 
PE--conjugated anti-mouse Ig, then blocked with mouse Ig, fol- 
lowed by staining with FITC-conjugated Ly 5.2 and biotinylated 
B220; Texas red-avidin was used for the next stage staining. 
Agar Colony Assay.for Myeloid Precursors.  The semi-solid agar 
cultures were performed according to the procedures described by 
Metcalf et al. (27). Briefly, equal volumes of double-strength cul- 
ture medium (DME-20% FCS) and double-strength agar (0.6%) 
were mixed at 37~  The cells to be cultured were added, and 1 
ml of the cell suspension in the agar medium was #petted into 
35-mm petri dishes containing the stimulus required for the prolifer- 
ation of myeloid precursors.  After mixing, the cultures were al- 
lowed to gel and then were incubated at 370C in 10% CO2, 90% 
air. The colonies were scored 7-14 d later. The stimulating factors 
used in this study were recombinant stem cell factor (27a) (200 
ng/ml), Ibl (100 U/ml), Ib3 (1,000 U/ml), M-CSF (1,000 U/ml), 
G-CSF (1,000 U/ml), GM-CSF (1,000 U/ml), and erythropoietin 
(EPO)  (1 U/ml). 
Preparation  for Light and Electron Microscopy.  For light micros- 
copy 40,000 purified cells were cytocentrifuged onto a glass slide, 
fixed in 89% methanol, 10% distilled water, and 1% acetic acid, 
and stained with Giemsa. For electron microscopy, the cells were 
fixed overnight in 2.5% glutaraldehyde in 0.1 M sodium cacodylate 
(pH  7.2),  then postfixed  for  1 h  at room temperature in 2% 
OsO~.  The fixed cells were stained en bloc with 4% uranyl ace- 
tate (aqua) at 4~  in the dark and dehydrated in graded acetones 
(10-100%).  The sample was infiltrated with Spurt resin, polymer- 
ized and sectioned, stained with 10% uranyl acetate for 5 min and 
then with Reyaold's lead citrate for 5 rain. The stained  sample 
was viewed on an electron microscope (model CM12; Philips Elec- 
tronic Instruments Co., Mahwah, NJ) at 60 kV. 
Results 
Sca-1 + $ca-2 + Fraction of the Low CD4 Precursor Population 
Contains Early Precursor Activity.  Sca-1 (Ly 6A/E) and Sca-2 
have been used to characterize stem cells and precursor ceils 
from bone marrow (5, 28).  To test the Sea-1 and Sca-2 ex- 
pression of the earliest intrathymic precursor cells, the depleted, 
CD8-,  CD3-,  CD2-, IL-2R-, and non-T lineage marker- 
negative thymocytes were stained in four colors with anti- 
bodies to Thy-l.1, HSA, Sca-1,  and Sca-2; the stained cells 
were then analyzed by flow cytometry. The staining pattern 
is shown in Fig. 1. The low CD4 precursor population stood 
out distinctly with low levels of Thy-1 and moderate levels 
of HSA (Fig.  1 A).  Our previous studies (7)  showed that 
these cells (within the gates shown in Fig. 1 A) all expressed 
moderate levels of CD4, high levels of Pgp-1, and very high 
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Figure  1.  Expression of Sca-1 and Sca-2 on the thymic low CD4 
precursor population. Thymocytes  were depleted of cells bearing CD3, 
CD8, CD2, and IL-2R, and of non-T lineage cells (see Materials and 
Methods). The depleted  population (<1% thymocytes)  was stained  in three 
colors with antibodies against Thy-1 (FITC-19F-12), HSA (PE-M1/69), 
and Sca-1 (biotin-El3 161-7) or Sca-2 0aiotin-E3  81-2). (A) HSA and Thy-1 
distribution, with the area previously  shown  to include  all early  T precursor 
cells (7) bound by the broken line. (/3) Distribution of $ca-1, and (C) the 
distribution of Sca-2 on this gated population  with the background fluores- 
cence is shown by a dotted line. One of two similar analyses  is presented. 
levels of H-2K, and included all the early thymocyte precursor 
activity of the depleted preparation. Separate experiments also 
established that these cells were MHC dass II (Ia)-negative 
or very low positive  (data not  shown).  When  this  gated 
precursor population was analyzed, it was dear that most 
cells (>90%) were positive for expression of both Sea-1 (Fig. 
1 B) and Sca-2 (Fig. 1 C). Further analysis (not shown) indi- 
cated that these two markers were tightly correlated, with 
most of the 5%  Sea-2-  cells also being Sea-l-. 
Day  14  Day  23 
i  f  I  i  i  i 
Sca-2 + 
i  i 
Sca-2- t 
,  & 
I00  i  0  I  i0  100  i000 
Donor  type  Thy-i 
Thymus reconstitution  activity of the Sc2-2  + and Sca-2- 
i  I 
2 
lo 
Figure  2. 
fractions  from the low CD4 precursor population. The low CD4 precursor 
population was isolated and stained as in Fig. 1 C, then sorted for cells 
that were Thy-1 low, HSA intermediate (using the gates of Fig. 1 A), 
and either Sca-2  + or Sca-2- (according to the distribution in Fig. 1 C). 
The sorted fractions  were then injected  into the thymus of  irradiated  Thy-1 
congenic mice (see Materials and Methods) using 9,000 cells per lobe for 
the major Sca-2  + population, and 1,800 cells per lobe for the minor Sca- 
2- population. At the times stated, suspensions of the pooled recipient 
thymus lobes were analyzed  for cells of donor Thy-1 type (Thy-l.1). No 
donor-derived cells were seen when the Sca-2- cells were injected. One 
of two similar experiments is presented. 
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Figure  3.  Expression orB220 
on the thymic low CD4 precursor 
population.  Thymocytes  were 
depleted of cells  beating  CD8, 
CD3,  CD2,  and  IL-2R,  and of 
non-T lineage cells, but were not 
depleted of cells  bearing B220. 
The  depleted  population  was 
stained in three colors with anti- 
bodies against Thy-I (FITC-19F- 
12), HSA (PE-M1/69), and B220 
(biotin-RA3-6B2). (A) Distribu- 
tion of Thy-1 and HSA and the 
gates for the low CD4 precursor 
population (broken line). (B) Ex- 
pression  of B220  on  the  gated 
precursor  population,  plotted 
against forward light scatter to 
provide an estimate of cell  size. 
Small cortical thymocytes gave a 
scatter value of 100 on this scale. 
As described by Spangrude et al.  (5,  29),  purified bone 
marrow stem cells are Sca-1 + but Sca-2-.  To test whether 
the precursor activity of our low CD4 precursor thymic popu- 
lation was derived from the majority of  cells that express Sca-2 
or from a small minority of Sca-2- cells that could possibly 
be bone marrow-derived stem cells, we separated Sca-2 § and 
Sca-2-  cells  by  sorting  and  then  examined their  thymic 
reconstitution ability after intrathymic injection. As shown 
in  Fig.  2,  9,000  Sca-2 §  cells  when  transferred,  produced 
20-30% donor-derived  cells at 14 d and 50-60% donor-derived 
cells at 23 d, a result similar to that obtained with the total 
low CD4 precursor population. In contrast, no donor-derived 
cells were detected at either time after transfer of 1,800 Sca- 
2-  cells, even though this number was large in proportion 
to their representation within the low CD4 precursor popu- 
lation.  The T  precursor activity was evidently within  the 
major Sca-2 +  subpopulation  and was  not  derived from a 
small number of Sca-2- cells resembling bone marrow stem 
cells. 
The B220-  Fraction of the Low CD4 Precursor Population 
Contains the Early Precursor  Activity.  In preliminary isolation 
protocols where anti-B220 was omitted from the depletion 
procedure (any thymic B cells being removed by the anti-Ig- 
coated beads), the Thy-l-low, HSA-intermediate, and CD4- 
intermediate fraction included a  10-15%  subpopulation of 
small-sized B220 § cells (Fig.  3).  In view of the finding by 
Strasser et al. (30) of a stem-cell-like tumor cell bearing both 
CD4 and B220,  the precursor function of the B220 § subset 
of our thymic low CD4 precursor preparation was assessed. 
Both  the  B220-  (major  subpopulation)  and  the  B220 § 
(minor subpopulation) cells were isolated as in Fig. 3, then 
transferred intrathymically to test for thymus reconstitution 
activity. All the activity of the Thy-l-low, HSA-intermediate, 
low CD4 precursor population could be accounted for by 
the major B220-  subpopulation, with no activity being de- 
tected from the B220 + cells (data not shown). Accordingly, 
in most subsequent experiments this B220 § subpopulation 
was removed from the preparation by including anti-B220 
in the depletionprocedure. 
The Fraction of the Low CD4 Precursor  Population Staining 
Brightly  with  Rhodamine Contains the  Early Precursor Ac- 
tivity.  Rhodamine 123 (Rh-123)  is a fluorescent vital dye 
that preferentially binds to mitochondrial membranes in living 
cells (31), the intensity of staining being related not only to 
the number of mitochondria per cell but also  to  the state 
of cellular activation (32). This dye has been used to separate 
activated from quiescent stem cells (33, 34). When the thymic 
low CD4 precursor population was stained with Rh-123, most 
Figure 4.  Morphological appearance 
of the low CD4 precursor population. 
The low CD4 precursors were purified 
by depletion and three-color sorting, 
then  cyto-centdfuged  and  Giemsa 
stained,  or fug'd and subjected to elec- 
tron  microscopy  (see  Materials  and 
Methods).  (A)  A  group  of Giemsa- 
stained  low CD4  precursor cells, in- 
cluding a cell in mitosis (x 2,000).  (B) 
An electron micrograph of a low CD4 
precursor cell (x 7,600). 
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95% Rah-123  hi cells were separated by sorting from the 5% 
Rh_1231o + re,a, and thymus reconstitution activity was as- 
sessed in experiments similar to those shown in Fig. 2. The 
Rh-123 ~ fraction showed high thymic reconstitution activi- 
ty, whereas no reconstitution was seen in the Rh-123  ~~ + reed 
cells (data not shown). Thus, the activity of the low CD4 
precursor population resided in the majority population of 
bright rhodamine staining, metabolically active cells. 
Morphological Appearance of tke Low CD4 Precursor  Popula- 
tion.  The low CD4 precursor population was purified using 
the full procedure, including depletion of B220 + cells and 
adherent calls. The general appearance of these preparations 
(Fig.  4, A  and B) was of cells intermediate between lym- 
phoblasts and purified hematopoietic stem cells (5, 35). Mi- 
totic figures were seen, in accordance with our previous data 
indicating that 14% of the ceUs were in S phase (7). Mito- 
chondria were plentiful, in accordance with the rhodamine 
staining data and the concept that the low CD4 precursors 
represent an active rather than a quiescent population. 
The Low CD4 Precursor  Does Not Contain CFU Activity.  Be- 
cause of the similarities in surface antigenic phenotype be- 
tween the thymic low CD4 precursor cells and bone marrow 
stem cells, it was important to determine whether the thymic 
precursor cells were also multipotent. As a first test we checked 
their ability to form erythroid and myeloid colonies in the 
Table  1.  Spleen Colony Assay (CFUs) 
No.  Colonies  Average colonies 
Cell source  injected  examined  per spleen 
d  n 
Thymic CD8-3-2-, 
IL-2R-,Thy-1 § , 
HSA+,H-2K  ~+ ,(low 
CD4  precursors)  30,000  8  0 
12  2 
Thymic CD8- 3- 2-, 
IL-2R-  (depleted 
only)  300,000 
Bone marrow  100,000 
Unseparated cells 
Published values 
Purified bone 
marrow stem cells  200 
12  1 
8  7 
12  14 
8  2 
12  20 
The full details of the spleen colony assay are given in Materials and 
Methods.  Results summarized in this table are the means of two experi- 
ments, each involving  three recipients per time point. The data for purified 
bone marrow stem cells are from previously published work (5), presented 
here for comparison. 
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spleen, the standard CFU assay. When purified thymic low 
CD4 precursor cells were transferred intravenously into lethally 
irradiated recipients, no spleen colonies were found after 8 d, 
and after 12 d an average of only two colonies were found 
per 30,000 cells injected (Table 1). Compared with purified 
bone marrow stem cells (5), the thymic low CD4 precursor 
population was, on a cell for cell basis,  1,000-fold less effec- 
tive at forming spleen colonies. To ensure that this lack of 
CFU capacity was not due simply to the antibodies on the 
cell surface preventing seeding in the spleen (36), the depleted 
thymocyte preparation was also tested for CFU activity be- 
fore coating the cells with antibodies for positive sorting. 
As shown in Table 1, this depleted preparation did not con- 
tain significant CFU activity. Thus, by the criterion of the 
CFU assay, the low CD4 precursor cells were unable to serve 
as precursors of the erythroid or myeloid lineages. 
The Low CD4 Precursor  Population Contains Few Cells Capable 
of Forming Myeloid or Erytkroid Colonies in Agar.  As a par- 
allel to the CFU tests, we checked whether the low CD4 
precursor population was able to form colonies in agar in 
the presence of growth factors capable of inducing precursor 
cells to develop into granulocytes, macrophages, or erythroid 
calls. In initial studies where depletion of adherent cells was 
not used, a mean of 7% of the low CD4 precursor popula- 
tion formed small clusters (<50 cells) and an occasional colony 
consisting entirely of macrophages, with no polymorpho- 
nuclear or erythroid cells. This observation confirmed that 
no multipotent cells were present, but suggested the pres- 
ence of some committed, late macrophage precursors in the 
preparation, despite the Mac-1 depletion step and the verified 
absence of Mac-1 + cells. Accordingly, a period of incubation 
on plastic dishes was introduced into the isolation protocol 
to  remove possible  macrophage precursors.  Only  a  small 
proportion of the ceils was removed by this process, and av- 
erage cell recoveries were not detectably reduced. After in- 
trathymic transfer into irradiated Thy-1 congenic recipients, 
the adherent cell-depleted preparation showed the normal 
distribution of thymocyte progeny 14 d after transfer, with 
an apparent expansion in numbers from 680- to 1,180-fold, 
certainly no lower than the average 500-fold expansion ob- 
served with preparations not depleted of adherent calls (7). 
However, now only between 0 and 0.7% of the cells in the 
adherent cell-depleted low CD4 precursor preparations gave 
clusters or colonies in agar. These few colonies consisted only 
of macrophages, with no polymorphs or erythroid cells. It 
was conduded that the few macrophage precursors present 
were separate from the precursor cells leading to the T lineage. 
Hematopoietic Lineage Reconstitution by the Low CD4 Precursor 
Population.  To assess further the developmental potential of 
the thymic low CD4 precursor population, the system of in- 
travenous transfer into mice differing at the Ly 5 locus was 
used (6). This system allowed even low levels of lineage recon- 
stitution to be analyzed (Fig.  5). This was important since 
to ensure the long-term survival of the recipient animals, 
recipient-type bone marrow cells were also transferred, which 
meant that the thymic precursors were competing with bone 
marrow stem cells for reconstitution "space." At weekly in- 
tervals 2-8 wk after transfer, we analyzed spleen and lymph =o 
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Figure  5.  Analysis of hemopoietic lineage reconstitution in spleen and 
lymph nodes by the thymic low CD4 precursor population. 30,000 purified 
low CD4 precursor cells, along with 40,000 unseparated  host type bone 
marrow cells, were intravenously transferred into irradiated mice differing 
at the Ly 5 locus (see Materials and Methods). 4 wk after reconstitution, 
the recipient spleen and lymph nodes (pooled) were analyzed for donor- 
derived cells by use of two-color flow cytometry with FITC-anti-Ly 5.2 
and biotinylated lineage marker antibodies, either anti-Thy-l.1, anti-B220, 
anti-Mac-I, or anti-Gr-1, with PE-Av as second stage￿9 In this experiment 
donor and host differed in both Ly 5 and Thy-1 allotypes,  so host type 
Thy-l.2 + cells were not stained. The result presented is representative of 
a series of similar experiments. 
nodes (pooled), bone marrow, and thymus (Figs. 6-8). These 
reconstitution  kinetics were compared directly with  those 
of a preparation  of bone marrow cells depleted of lineage- 
committed cells and enriched for multipotent precursor cells 
(the "Lin-  BM" preparation) to ascertain that any reconsti- 
tution by the thymic precursor cells was not due to a few 
contaminating  multipotent  stem cells of the bone-marrow 
type. 
In the thymus of recipient mice the maximal level of recon- 
stitution by the low CD4 precursors was obtained 3 wk after 
intravenous transfer,  and it declined rapidly thereafter (Fig. 
6 A).  This peak of transient  reconstitution  was similar to 
that seen with intrathymic transfer (7). The level of reconsti- 
tution (30% donor-derived cells) was higher than that seen 
in other lymphoid organs (compare with Figs.  7 and 8) and 
was similar  to the level  obtained with bone marrow  stem 
cells at this time point. However, the reconstitution by Lin- 
BM cells rose beyond this, reaching a peak at 4 wk, and this 
high level of reconstitution continued to 8 wk (presumably 
by continuous seeding from bone marrow). Overall,  the results 
suggested that the low CD4 precursor cells gave a transient 
rather than a self-renewing pattern of reconstitution and had 
a low expansion potential as compared with bone marrow 
stem cells. 
The nature of the progeny cells in the recipient thymus 
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Figure  6.  Thymic reconstitution by the thymic low CD4 precursors 
and Lin-  BM cells. 30,000  purified  low CD4 precursor cells or 3,000 
Lin- BM cells, along with 40,000 host-type unseparated  BM cells, were 
intravenously  injected into lethally irradiated recipient mice differing at 
the Ly 5 locus. After the times indicated, the relative level of donor-derived 
cells and the lineage distribution of donor-derived cells in the recipient 
thymuses  were revealed by staining the cells in two colors with FITC- 
conjugated anti-donor type Ly 5 (Ly 5.2) and biotinylated lineage-specific 
antibodies, either anti-Thy-l.1,  anti-B220,  anti-Mac-I, or anti-Gr-1, fol- 
lowed by PE-Av as a second stage￿9 (A) Overall reconstitution at each time 
point by the low CD4 precursor population and the Lin- BM ceils, given 
by the percent of donor-type Ly 5.2 + cells in the recipient thymuses. (B) 
Lineage distribution among the donor-derived cells, given by the percent 
of cells bearing each lineage marker among all Ly 5.2 + cells. At each time 
point, the data represented are the mean values of three experiments (low 
CD4 precursors)  or two experiments (Lin- BM); each experiment in- 
cluded three recipient mice per time point￿9 
was examined at each time point (Fig.  6 B). Only Thy-1 § 
donor-derived cells were detected from both the low CD4 
precursors and the Lin-  BM populations. In separate experi- 
ments (data not shown), it was verified that at 3 wk the donor- 
derived cells consisted mainly of CD4 +  8 + cortical thymo- 
cytes, with  a small proportion  of CD4+8 -  and  CD4-8 + 
mature  thymocytes,  as  seen  previously  with  intrathymic 
transfer  (7).  No detectable level of production  of either B 
cells or myeloid cells was seen (Fig.  6 B). Similar restriction 
of the low CD4 precursor cells to T cell production was seen 
in separate experiments when they were injected intrathymi- 
cally and Ly 5 was used to track the progeny (data not shown). 
1622  Lymphoid Precursors  in the Thymus In recipient bone marrow the level of reconstitution by 
the low CD4 precursor population was very low at all time 
points (Fig. 7A). The maximum was '~3% at 3 wk, whereas 
Lin-  BM  cells  gave 60-70%  donor-derived cells.  It  was 
nevertheless possible to determine the expression of lineage 
markers by the cells derived from low CD4 precursors (Fig. 
7 B). In contrast to the results with Lin- BM, the majority 
of  progeny were Thy-l-bearing cells. This result was obtained 
even at the 2-wk time point; the nature of these early progeny 
cells was not further determined. Very few of the progeny 
were Mac-1 § or Gr-1 +, and the small proportions recorded 
were close to the background limits of analysis.  However, 
the surprising result was that the low CD4 precursors gave 
a significant proportion of B220 § progeny at all time points, 
a proportion similar to that obtained with Lin-  BM. 
In the spleen and lymph nodes, the peak level of reconsti- 
tution by the low CD4 precursor population at 4 wk was 
'~10% (Fig.  8 A), being higher than that in bone marrow 
but lower than that in thymus. However, the reconstitution 
was more persistent than that obtained in thymus or bone 
marrow.  Since in preliminary experiments the overall  pat- 
tern seemed similar in spleen and lymph nodes, cells from 
these two sources were pooled in the experiments given in 
Fig.  8. An example of the analysis at a 4-wk time point is 
given in Fig.  5.  As with bone marrow, a high proportion 
of the progeny of the low CD4 precursors were Thy-1 +, 
even at the earliest time points (Fig.  8 B); many of these 
cells  expressed only low levels of Thy-1.  Very few of the 
progeny were Mac-1 §  or Gr-1 §  (and the levels measured 
were close to the background for this analysis),  in contrast 
to high inddence of myeloid cells seen at the early time points 
when Lin-  BM was transferred. However, as found in the 
bone marrow, the B lineage as well as the T lineage was recon- 
stituted by the thymic low CD4 precursor cells, since 20-40% 
of the progeny were B220 + over the 2-8-wk period (Figs. 
7 B  and 8 B). 
Thy-I § Progeny of the Low  CD4  Precursors Are  T  Cells. 
To determine whether the Thy-1 * progeny of the low CD4 
precursors were normal T cells, the recipient spleen and lymph 
node cells were analyzed 3 and 4 wk after transfer by mul- 
ticolor staining with anti-Ly 5.2, anti-Thy-1,  anti-CD4, and 
anti-CD8.  The gated Ly 5.2 + Thy-1 § cells were found to 
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Figure  7. 
population and Lin- BM cells. The procedures for intravenous transfer, 
analysis of donor-derived cells, and other details are as described in Fig. 
6. (A) Overall reconstitution by both the low CD4 precursor population 
and the Lin -  BM ceils in the recipient bone marrow. (B) The lineage dis- 
tn'bution  of donor-derived cells. Proportions <3% in the lower pands were 
within the background range. 
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Spleen and lymph node  reconstitution by the low CD4 
precursor population and Lin - BM cells. The procedures for intravenous 
reconstitution,  analysis of donor-derived cells, and other details are the 
same as described in Fig. 6. (A) Overall reconstitution by both low CD4 
precursors and the l.in  - BM cells in the recipient spleen and lymph nodes 
(pooled). (B) Lineage distribution of donor-derived cells. Proportions <3% 
in the lower panels were within the background  range. A. 
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Figure 9.  Further analysis of 
donor-derived B220 + cells in the 
spleen and lymph nodes of irradi- 
ated  mice  reconstituted  with 
thymic low CD4 precursors. In 
the same experiment described in 
Fig. 5, the pooled cell suspension 
from recipient spleen and lymph 
nodes was stained in three fluores- 
cent colors, first  with  PE-con- 
jugated anti-mouse Ig, followed 
by blocking with mouse Ig, then 
staining with  FITC-conjugated 
anti-Ly 5.2 and biotinylated B220, 
using TR-Av as second stage. The 
stained cells were then analyzed 
by flow cytometry.  The donor- 
derived Ly 5.2 + cells, or the Ly 
5.2 + B220 + cells, were gated for 
further characterization.  (A) B220 
and surface Ig distribution  on the 
gated  Ly  5.2 +  donor-derived 
cells. (B) Forward light scatter of 
the gated Ly 5.2 + B220 + cells. 
The dotted line shows the.  forward 
light  scatter  of normal splenic 
B220 + cells. 
be 65% CD4+8 -  and 32%  CD4-8 + (data not shown), a 
distribution similar to that of normal peripheral T  cells. 
The 13220  + Progeny of the Low CD4 Precursors Are B Cells. 
To  determine whether  the B220 + cells  derived from the 
thymic low CD4 precursors were conventional B cells, they 
were further analyzed by multicolor staining of  recipient spleen 
and lymph node cells with antibodies to donor Ly 5, B220, 
and mouse Ig, and by gating during analysis for donor-type 
Ly 5.2 + cells. The donor-derived B220 + cells were all sur- 
face Ig + and had the light scatter characteristics  of normal 
splenic B lymphocytes (Fig. 9). In separate experiments the 
B220 § donor-derived cells were stained with anti-CD5 and 
were found to be predominantly CDS-  (data not shown). 
Thus,  most  B220 §  donor-derived  cells  appeared  to  be 
normal B cells. 
13220 §  B-Cell Progeny  of the Low CD4  Precursors Derive 
from B220-  Cells.  To ascertain  that the B cells developing 
from the low CD4 precursor preparation did not derive from 
some B220 + pre-B  cell contaminants, B220 depletion was 
omitted from the isolation protocol, and the resultant popu- 
lation was stained and sorted into distinct B220 + and B220- 
components (shown in Fig. 3). The sorted fractions were trans- 
ferred intravenously into Ly 5 congenic recipients,  and 4 wk 
later the spleen and lymph nodes (pooled), the bone marrow, 
and the thymus were analyzed for donor-derived cells. Only 
the  B220-  fraction showed significant reconstitution ac- 
tivity, the B220 + fraction showing levels dose to the back- 
ground  for  the  system  (Table  2).  On  reconstitution  the 
B220-  fraction gave both Thy-1 + and the B220 + donor- 
derived cells, in spleen and lymph nodes and in bone marrow, 
but only Thy-1 § cells in the thymus. This result is exactly 
the same as that found for the total low CD4 precursor popu- 
lation. In separate experiments (not shown), similar recon- 
stitution of both the Thy-1 + and the B220 + lineage was ob- 
tained  with  adherent  cell-depleted  low  CD4  precursor 
populations. Clearly all the T  and B precursor activity of 
the thymic low CD4 precursor preparations resided in the 
B220-  and nonadherent cells, which constitute the bulk of 
this preparation. 
Discussion 
Surface Phenotype of Thymic Low CD4 Precursors Compared 
to Bone Marrow Stem Cells.  In this study we have compared 
the earliest T precursor cells from the adult mouse thymus 
with bone marrow hemopoietic stem cells. Since it was not 
clear whether all the cells in our thymic low CD4 precursor 
Table  2.  Reconstitution  Activity  of the B220-  and B220 + Fractions 
Donor-type cells 
Recipient  Cell injected  No.  Donor 
organs  (i.v.)  injected  Ly 5.2 +  Thy-1 §  B220 +  Mac-1 *  Gr-1 + 
Thymus  B220-  30,000  1.5  97  0.7  0  0 
B220 +  4,500  0.1  -  *  -  -  - 
Spleen and lymph nodes  B220-  30,000  9.1  68  32  1.8  1.1 
B220 +  4,500  0.1  .... 
Bone marrow  B220-  30,000  1.1  76  23  3.8  3.5 
B220 +  4,500  0  .... 
The B220- and B220 + fractions of a low CD4 precursor  population prepared without prior B220 depletion were sorted on the basis of staining 
analysis (Fig. 3). Both fractions were intravenously  injected into irradiated mice differing at the Ly 5 locus. 4 wk later the recipient thymus, spleen, 
lymph nodes (pooled), and bone marrow were analyzed for donor-derived  cells, as described in Fig.  5 and Materials and Methods. 
* The level of reconstitution by the B220 + fraction was too low to determine the lineage distribution. The proportion of Mac-1 + and Gr-1 + cells 
among the Ly 5.2 + cells was within the background range (0-2.5%) for spleen and lymph nodes, and only marginally above it for bone marrow. 
1624  Lymphoid Precursors in the Thymus preparation  were active as precursors,  we used some addi- 
tional  markers in an  attempt  to subdivide the population. 
The markers were Sca-1 (Ly 6A/E),  Sca-2,  B220, and Kh- 
123 binding,  all of which had been used previously for sub- 
dividing  and  characterizing  bone  marrow  stem  cells  and 
precursor  cells.  Precursor  activity was associated with  the 
nonadherent,  Sca-2 + , B220-, and Rh-123  hi cells, which rep- 
resent the vast majority of cells in this preparation.  We have 
now refined the isolation protocol to exclude any B220 § or 
adherent cells. The combination of this work and our previous 
study (7) indicates that the low CD4 precursor preparation 
consists almost entirely of CD4 m~a, CD8-,  CD3-,  CD2-, 
B220-,  IL-2Koe-, HSA  m~a, Thy-1 l~  class I MHC hi, class II 
MHC  l~  Pgp-1(CD44) hi, Rh-123 hi, Sca-1 +, and Sca-2 + cells, 
which are also negative for a series of non-T lineage markers. 
We have  now confirmed  the correlation  of function  with 
phenotype for 12 of these 14 markers.  By these criteria the 
early precursor activity is associated with the phenotypically 
homogeneous majority (>95%) population, rather than with 
any minority  subpopulation. 
The fact that the thymic early precursor cells are Sca-1 +, 
Sca-2 § gives some insight into their relationship with bone 
marrow  hemopoietic  stem cells,  which  are  Sca-l+,  Sca-2- 
(5,  29).  In  a recent  study by Spangrude  and Scollay (29), 
purified bone marrow stem cells were injected into the thymus 
of irradiated recipients, and the phenotype of the donor-derived 
cells  was determined.  The  only change  detected  7 d  after 
transfer was the acquisition of surface Sca-2.  Only later did 
the progeny cells show the sequential expression of the markers 
characteristic  of the later steps of thymocyte development. 
This result suggests that the cells in our low CD4 precursor 
population are the direct progeny of bone marrow hemopoietic 
stem cells, with the Sca-2 expression characterizing the early 
expansion  phase in  the thymus.  The  high level of Rh-123 
staining, the appearance of the cells, their relatively high mi- 
totic index, and our earlier cell-cycle analyses  (7) are all con- 
sistent with this picture of an activated, expanding precursor 
population. 
Developmental Potential of Thymic Low CD4 Precursors  Com- 
pared with Bone Marrow Stem  Cells.  The  second aspect of 
this study was to determine whether the thymic early precursor 
cells were multipotent  like bone marrow  stem cells,  or re- 
stricted to T lymphocyte development, like the CD4-8-  in- 
trathymic precursor cells. The virtual lack of capacity to form 
erythroid or myeloid colonies in the spleen and in agar cul- 
ture, in contrast to that of bone marrow stem cells, suggested 
that  this thymic precursor population was restricted in de- 
velopmental  potential. 
However, it could be argued that both these colony assays 
measure cells  that  are in a later stage of development  than 
a true hemopoietic stem cell.  Therefore,  we tested the lin- 
eage commitment  of the thymic low CD4 precursor after 
intravenous transfer,  using the Ly 5 marker to trace the de- 
velopment  of precursor  cells  into  lymphoid  and  myeloid 
lineages. We made a direct comparison with an enriched popu- 
lation of bone marrow stem cells (Lin-  BM), which enabled 
us to exclude the possibility that  any activity measured in 
the thymic precursor population  was due to a minor  sub- 
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population of contaminating multipotent stem cells. Because 
the  developmental  kinetics  of the  myeloid  and  lymphoid 
lineages are different, a full kinetic study of lineage reconsti- 
tution  was undertaken. 
It was clear that the number of Ly 5-bearing progeny cells 
obtained after intravenous transfer of the low CD4 precursors 
was much lower than that obtained from bone marrow stem 
cells.  This  finding  may be  due  in  part  to  the  low  CD4 
precursors being poor competitors for developmental space 
with the host-type bone marrow stem cells, which were in- 
jected to rescue recipient  animals  from irradiation-induced 
death.  However, it also suggests that the thymic precursors 
have a low potential for expansion,  as compared with bone 
marrow stem cells.  It was also notable that the thymic low 
CD4 precursors gave a transient reconstitution whereas the 
Lin-  BM cells gave a more prolonged reconstitution.  This 
all indicates that  the low CD4 precursors  have  a relatively 
limited expansion potential compared with true self-renewing 
stem cell. 
The low CD4 precursors  were able to  seed the thymus 
after intravenous transfer,  and the results suggested a relative 
preference for thymic seeding as compared with Lin-  BM 
cells.  Within  the thymus only T  cell development was de- 
tected, but the same result was seen after intravenous injec- 
tion of Lin-  BM,  presumably because of selective seeding 
of lymphoid-committed  precursors.  However, a restriction 
to  T  cell development  was  also  seen  when  the  low CD4 
precursors  were injected directly into  the thymus,  a result 
different from that seen with purified bone marrow stem cells 
(29), which then give 50% myeloid cells as well as T lineage 
cells. 
Despite the preference for thymic seeding, the low CD4 
precursors did produce progeny in bone marrow, spleen, and 
lymph node.  The striking  finding was that  not only were 
Thy-1 §  T  cell progeny  found,  but  also  B220 + B  lineage 
cells. These B220 + progeny were surface lg + , CD5-,  small 
lymphoid cells, and so appeared to be normal B lymphocytes. 
However, no significant levels of Mac-1 * or Gr-1 § progeny 
were detected at any time point, an observation in agreement 
with the spleen colony assay. This observation indicates that 
the thymic low CD4 precursors had a developmental poten- 
tial different from that  of bone marrow  hemopoietic stem 
cells.  The  B cell  development  from  the  thymic low CD4 
precursor preparation  was unlikely to be due to a low level 
of contamination  with  multipotent  stem  cells,  since  our 
Lin-  BM preparation gave a quite different pattern of recon- 
stitution.  Nor is it likely to be due to contamination  with 
the normal type of B220 + B-committed precursor cells (37), 
since  all  our  B  precursor  activity  was  from  the  B220- 
majority population,  and none was detected from a minor 
B220 §  fraction  when  these were separately isolated. 
ALymphoid-committedPrecursor?  A restricted precursor cell 
common to the T and B lymphoid lineages is commonly as- 
sumed to exist in bone marrow, although direct evidence for 
this is meagre. The strongest evidence comes from long-term 
bone marrow cultures, where a restricted stem cell capable 
of generating both B and T  lymphocytes has been detected 
(38-40). The results obtained in our study strongly suggest the low CD4 precursor population from adult mouse thymus 
consists of lymphoid-committed precursors, which normally 
develop into both ot/B and 3'/~ T cells (7), but which retain 
a capacity to develop into B cells.  Since the developmental 
fate of these thymic precursor cells is environmentally deter- 
mined,  the capacity to produce B cells may not be utilized 
within the thymus. Even when these precursors are injected 
intravenously, T cell development predominates, probably be- 
cause of a bias to thymic seeding,  but B cell development 
occurs from some of the precursors that seed bone marrow. 
This lack of absolute commitment to a particular lymphoid 
lineage agrees with our previous findings (7) that this popu- 
lation has TCR-3, TCR-3,, and IgH genes in germline state. 
However, we cannot as yet eliminate the alternative possi- 
bility that our thymic low CD4 precursor population con- 
sists  of a mixture  of separate,  already committed T  and B 
precursors.  The latter would have to be B220- B precursors, 
and the reason for their existence in the thymus would be 
obscure. Although our final low CD4 precursor population 
appears homogeneous on one- to four-color flow-cytometric 
analysis using 14 separate phenotypic markers, closely related 
but separate B and T precursors could have the same surface 
phenotype. Some form of clonal analysis will be required to 
demonstrate  that  a single precursor cell has both B and T 
developmental potential. This analysis will he difficult to ob- 
tain  since an individual  cell will tend  to produce either  B 
or T  cells according to where it seeds,  and because the ex- 
pansion potential of these precursor cells is lower than that 
of bone marrow  stem cells. 
These studies raise  some interesting  questions about the 
stage at which development becomes lymphoid restricted. 
In contrast  to recent results with human  thymus (41),  the 
earliest precursors  we detected in the mouse thymus were 
already lymphoid restricted and distinguishable (by Sca-2 ex- 
pression) from multipotent  stem cells. However, we cannot 
tell whether they seeded the thymus in this state, or whether 
they became lymphoid restricted very soon after arrival,  since 
most of the precursors we isolated must be expanded ver- 
sions of the few cells originally seeding from bone marrow 
(42). We favor the view that the thymus is seeded by lymphoid- 
restricted cells,  since if multipotent  precursors  are injected 
directly into the thymus,  they produce substantial myeloid' 
development, much more than normally detected within the 
thymus  (29).  In  this context  our current  attempts  to find 
an equivalent to our low CD4 precursor cell in bone marrow 
should provide some insights. 
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